Chirag Desai

Chirag Desai is a seasoned professional with extensive experience in oncology and biomedical sciences. Currently serving as Senior Director of Global Oncology Biomarker and CDx Strategy at Daiichi Sankyo, Inc. since April 2019, Chirag previously held leadership roles at BioReference Laboratories, focusing on oncology strategic partnerships and marketing for oncology diagnostics. Earlier career experiences include positions at Celgene, where responsibilities involved pricing, market access, and strategic marketing, and various roles in financial analysis and business consulting at Nielsen, MCI, and KPMG. Chirag holds an MBA in Marketing from Rutgers University - Newark, an MS in Biomedical Sciences from the University of Medicine and Dentistry of New Jersey, and a B.B.A. in Accounting from James Madison University.